Alessandra Micaela Villa appointed Director of Platform Development Rob Roovers appointed Director of Preclinical Development AMSTERDAM, Dec. 10, 2024 /PRNewswire/ — Kling Biotherapeutics (“Kling” or “the Company”), a biotech company developing antibody-based drugs for cancer and…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.